FAM204A

gene
On this page

Also known as FLJ13188bA319I23.1

Summary

FAM204A (family with sequence similarity 204 member A, HGNC:25794) is a protein-coding gene on chromosome 10q26.11, encoding Protein FAM204A (Q9H8W3).

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 41 total
  • MANE Select transcript: NM_022063

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25794
Approved symbolFAM204A
Namefamily with sequence similarity 204 member A
Location10q26.11
Locus typegene with protein product
StatusApproved
AliasesFLJ13188, bA319I23.1
Ensembl geneENSG00000165669
Ensembl biotypeprotein_coding
Entrez63877

Gene structure

Transcript identifiers

Ensembl transcripts: 33 — 26 protein_coding, 3 protein_coding_CDS_not_defined, 3 retained_intron, 1 nonsense_mediated_decay

ENST00000369170, ENST00000369172, ENST00000369183, ENST00000452252, ENST00000467890, ENST00000469758, ENST00000470476, ENST00000487269, ENST00000490048, ENST00000491416, ENST00000885074, ENST00000885075, ENST00000885076, ENST00000885077, ENST00000885078, ENST00000885079, ENST00000885080, ENST00000885081, ENST00000885082, ENST00000885083, ENST00000885084, ENST00000885085, ENST00000885086, ENST00000885087, ENST00000885088, ENST00000935478, ENST00000935479, ENST00000935480, ENST00000935481, ENST00000942972, ENST00000942973, ENST00000942974, ENST00000942975

RefSeq mRNA: 2 — MANE Select: NM_022063 NM_001134672, NM_022063

CCDS: CCDS7605

Canonical transcript exons

ENST00000369183 — 9 exons

ExonStartEnd
ENSE00001362266118341727118341927
ENSE00001448969118297925118310908
ENSE00003289621118335396118335426
ENSE00003565182118311207118311313
ENSE00003639330118336182118336423
ENSE00003648091118326154118326243
ENSE00003663616118335554118335641
ENSE00003790791118335114118335213
ENSE00003841347118342270118342324

Expression profiles

Bgee: expression breadth ubiquitous, 266 present calls, max score 98.85.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 32.9371 / max 753.4331, expressed in 1801 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
11163532.93711801

Top tissues by expression

288 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370198.85gold quality
monocyteCL:000057696.92gold quality
mononuclear cellCL:000084296.49gold quality
leukocyteCL:000073896.26gold quality
left testisUBERON:000453395.42gold quality
right testisUBERON:000453495.20gold quality
tendonUBERON:000004395.01gold quality
ventricular zoneUBERON:000305394.85gold quality
tibial arteryUBERON:000761094.63gold quality
gall bladderUBERON:000211094.62gold quality
popliteal arteryUBERON:000225094.62gold quality
testisUBERON:000047394.52gold quality
rectumUBERON:000105294.49gold quality
ganglionic eminenceUBERON:000402394.37gold quality
mucosa of stomachUBERON:000119994.15gold quality
muscle layer of sigmoid colonUBERON:003580593.92gold quality
cortical plateUBERON:000534393.86gold quality
prefrontal cortexUBERON:000045193.85gold quality
aortaUBERON:000094793.85gold quality
body of pancreasUBERON:000115093.79gold quality
lower esophagus muscularis layerUBERON:003583393.74gold quality
gastrocnemiusUBERON:000138893.72gold quality
lower esophagusUBERON:001347393.72gold quality
left coronary arteryUBERON:000162693.62gold quality
hindlimb stylopod muscleUBERON:000425293.62gold quality
subcutaneous adipose tissueUBERON:000219093.55gold quality
caudate nucleusUBERON:000187393.51gold quality
saphenous veinUBERON:000731893.42gold quality
anterior cingulate cortexUBERON:000983593.40gold quality
esophagogastric junction muscularis propriaUBERON:003584193.40gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes9.84
E-GEOD-100618no638.87
E-MTAB-6142no128.88
E-HCAD-13no2.80

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

86 targeting FAM204A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-656-3P100.0072.152788
HSA-MIR-12118100.0065.881270
HSA-MIR-3646100.0073.565283
HSA-MIR-5692A100.0074.406850
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-428299.9975.366408
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-4760-3P99.9370.502385
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-806399.9169.763146
HSA-MIR-368699.9070.532432
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-153-5P99.8973.866317
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-579-3P99.8671.663628
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-664B-3P99.8471.653590
HSA-MIR-374C-5P99.8072.062910
HSA-MIR-655-3P99.8072.192909
HSA-MIR-4694-3P99.7969.532640
HSA-MIR-1273H-5P99.7766.322471
HSA-MIR-7856-5P99.7569.992901

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriofam204aENSDARG00000039699
mus_musculusFam204aENSMUSG00000057858
rattus_norvegicusFam204aENSRNOG00000009830

Protein

Protein identifiers

Protein FAM204AQ9H8W3 (reviewed: Q9H8W3)

All UniProt accessions (3): Q9H8W3, F2Z2Y3, Q5T374

RefSeq proteins (2): NP_001128144, NP_071346* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR037690FAM204AFamily

UniProt features (8 total): compositionally biased region 3, sequence conflict 2, chain 1, region of interest 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H8W3-F171.340.35

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 102 (showing top): MYAATNNNNNNNGGC_UNKNOWN, MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN, NUYTTEN_EZH2_TARGETS_DN, JOHNSTONE_PARVB_TARGETS_3_DN, NFY_Q6_01, RAO_BOUND_BY_SALL4_ISOFORM_B, DCA_UP.V1_DN, ASH1L_TARGET_GENES, CIITA_TARGET_GENES, NFE2L1_TARGET_GENES, TAF9B_TARGET_GENES, ZIM3_TARGET_GENES, ZNF512B_TARGET_GENES, MIR616_5P, MIR371B_5P

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1

Protein interactions and networks

STRING

376 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
FAM204ATMEM184CQ9NVA4618
FAM204AHSF2Q03933539
FAM204AMFAP3LO75121528
FAM204ARAB11FIP2Q7L804477
FAM204AC7orf25Q9BPX7477
FAM204ACHCHD3Q9NX63456
FAM204AFAM133BQ5BKY9437
FAM204AANKRD40Q6AI12435
FAM204ANAA10P41227434
FAM204AFAM110BQ8TC76431
FAM204ATMEM179Q6ZVK1424
FAM204ASMU1Q2TAY7410
FAM204AHAUS8Q9BT25386
FAM204AEXOC4Q96A65366
FAM204ACLIP3Q96DZ5348

IntAct

24 interactions, top by confidence:

ABTypeScore
SMYD1FAM204Apsi-mi:“MI:0915”(physical association)0.670
FAM204ASMYD1psi-mi:“MI:0915”(physical association)0.670
FHL2FAM204Apsi-mi:“MI:0915”(physical association)0.560
KDM1AFAM204Apsi-mi:“MI:0915”(physical association)0.560
SPANXN2FAM204Apsi-mi:“MI:0915”(physical association)0.560
FAM177A1SLC27A2psi-mi:“MI:0914”(association)0.530
FXYD1GCHFRpsi-mi:“MI:0914”(association)0.530
CCDC60DCP1Bpsi-mi:“MI:0914”(association)0.530
CCDC60ZNF593psi-mi:“MI:0914”(association)0.350
S100A6VWA8psi-mi:“MI:0914”(association)0.350
H2AJWDR46psi-mi:“MI:0914”(association)0.350
SERF2WDR46psi-mi:“MI:0914”(association)0.350
CRCPSRCpsi-mi:“MI:0914”(association)0.350
PLGRKTVPS13Cpsi-mi:“MI:0914”(association)0.350
SPANXN2FAM204Apsi-mi:“MI:0915”(physical association)0.000
SMYD1FAM204Apsi-mi:“MI:0915”(physical association)0.000

BioGRID (32): FAM204A (Affinity Capture-MS), FAM204A (Affinity Capture-MS), HAT1 (Affinity Capture-MS), KPNB1 (Affinity Capture-MS), NPEPPS (Affinity Capture-MS), KPNA2 (Affinity Capture-MS), KPNA3 (Affinity Capture-MS), COPG1 (Affinity Capture-MS), FAM204A (Affinity Capture-MS), FAM204A (Affinity Capture-MS), FAM204A (Affinity Capture-MS), FAM204A (Two-hybrid), FAM204A (Two-hybrid), FAM204A (Two-hybrid), SPANXN2 (Two-hybrid)

ESM2 similar proteins: A0AUP1, A4II15, A7MCB7, E1C760, F6RRD7, F7AEX0, P14629, P78316, Q1L8X2, Q28DG8, Q2IA00, Q3T071, Q3U155, Q3ZCI6, Q4R6T7, Q4R8R3, Q4R8V8, Q4V7N4, Q5PQS7, Q5R939, Q5RA37, Q5XI65, Q5ZIH9, Q5ZIM6, Q6DFL5, Q6IEG0, Q6PBE2, Q6PII3, Q7SYB2, Q7ZXA8, Q80VN0, Q8C6C7, Q8C9J3, Q8CIL4, Q8IXW5, Q8R3N1, Q8R3N6, Q8VYD3, Q93VM9, Q95JM8

Diamond homologs: Q3ZCI6, Q5R939, Q8C6C7, Q9H8W3

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

41 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance27
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1757 predictions. Top by Δscore:

VariantEffectΔscore
10:118309870:A:ACdonor_gain1.0000
10:118311199:AAACT:Adonor_loss1.0000
10:118311200:AACTC:Adonor_loss1.0000
10:118311201:ACTC:Adonor_loss1.0000
10:118311202:CTCAC:Cdonor_loss1.0000
10:118311203:TCACC:Tdonor_loss1.0000
10:118311204:CACC:Cdonor_loss1.0000
10:118311205:A:Cdonor_loss1.0000
10:118311205:AC:Adonor_gain1.0000
10:118311205:ACC:Adonor_gain1.0000
10:118311205:ACCC:Adonor_gain1.0000
10:118311206:C:CGdonor_loss1.0000
10:118311206:CC:Cdonor_gain1.0000
10:118311206:CCC:Cdonor_gain1.0000
10:118311206:CCCC:Cdonor_gain1.0000
10:118311309:CCAAG:Cacceptor_gain1.0000
10:118311310:CAAG:Cacceptor_gain1.0000
10:118311310:CAAGC:Cacceptor_gain1.0000
10:118311311:AAG:Aacceptor_gain1.0000
10:118311312:AG:Aacceptor_gain1.0000
10:118311312:AGCTA:Aacceptor_loss1.0000
10:118311313:GCT:Gacceptor_loss1.0000
10:118311314:C:CCacceptor_gain1.0000
10:118311315:T:Cacceptor_loss1.0000
10:118311321:T:Cacceptor_gain1.0000
10:118311321:T:TCacceptor_gain1.0000
10:118326149:CTCA:Cdonor_loss1.0000
10:118326150:TCA:Tdonor_loss1.0000
10:118326151:CA:Cdonor_loss1.0000
10:118326152:A:ACdonor_gain1.0000

AlphaMissense

1551 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
10:118310887:C:AW224C1.000
10:118310887:C:GW224C1.000
10:118310889:A:GW224R1.000
10:118310889:A:TW224R1.000
10:118310878:T:AK227N0.999
10:118310878:T:GK227N0.999
10:118310888:C:GW224S0.999
10:118310905:A:CF218L0.999
10:118310905:A:TF218L0.999
10:118310907:A:GF218L0.999
10:118311209:C:AW216C0.999
10:118311209:C:GW216C0.999
10:118311211:A:GW216R0.999
10:118311211:A:TW216R0.999
10:118310869:C:AM230I0.998
10:118310869:C:GM230I0.998
10:118310869:C:TM230I0.998
10:118310879:T:AK227I0.998
10:118310890:T:AR223S0.998
10:118310890:T:GR223S0.998
10:118310896:C:AK221N0.998
10:118310896:C:GK221N0.998
10:118311292:C:GA189P0.998
10:118310868:C:GG231R0.997
10:118310868:C:TG231R0.997
10:118310875:G:CS228R0.997
10:118310875:G:TS228R0.997
10:118310877:T:GS228R0.997
10:118310880:T:GK227Q0.997
10:118310891:C:GR223T0.997

dbSNP variants (sampled 300 via entrez): RS1000021509 (10:118299453 C>A,T), RS1000105366 (10:118299723 T>C), RS1000115220 (10:118299447 T>A,C), RS1000278370 (10:118316720 G>A), RS1000297430 (10:118336618 A>C), RS1000309289 (10:118316366 C>T), RS1000321600 (10:118305619 G>T), RS1000428657 (10:118313558 T>C,G), RS1000477780 (10:118299242 G>C), RS1000600448 (10:118304562 C>T), RS1000610891 (10:118318376 C>T), RS1000645067 (10:118317999 C>A), RS1000668244 (10:118312421 C>T), RS1000670612 (10:118305909 T>C), RS1000827708 (10:118325170 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST006858_1Leisure-time exercise behaviour (age-stratified)1.000000e-07
GCST012322_45Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder1.000000e-09

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0000483exercise
EFO:0004530triglyceride measurement
EFO:0005658response to selective serotonin reuptake inhibitor

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
Phenylmercuric Acetateaffects cotreatment, decreases expression2
Valproic Acidaffects expression, increases expression2
dicrotophosdecreases expression1
afimoxifenedecreases expression, decreases reaction1
sodium arseniteaffects cotreatment, increases abundance, increases expression1
manganese chlorideincreases abundance, increases expression, affects cotreatment1
di-n-butylphosphoric acidaffects expression1
perfluoro-n-nonanoic acidincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
dorsomorphindecreases expression, affects cotreatment1
Air Pollutantsdecreases expression, increases abundance1
Arsenicaffects cotreatment, increases abundance, increases expression1
Benzo(a)pyrenedecreases expression1
Carbamazepineaffects expression1
Estrogensdecreases expression, decreases reaction1
Manganeseincreases abundance, increases expression, affects cotreatment1
Methyl Methanesulfonateincreases expression1
Zincdecreases expression1
Cyclosporineincreases expression1
Antirheumatic Agentsincreases expression1
Cadmium Chloridedecreases expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.